An Abbott official took to social media today to share that the company added Laralab to its portfolio of digital offerings.
The Chatbot Assessment Reporting Tool (CHART) guidelines, published in the BMJ and other journals in August, 2025, advise on the reporting of generative artificial intelligence (AI)-driven chatbots.